We report that OPA1 is selectively upregulated in metastatic breast cancer irrespective of the observed fragmented mitochondrial phenotype, and that its genetic or pharmacological inhibition selectively limits proliferation and migration in metastatic over normal and transformed breast cells. Here, OPA1 is linked to breast carcinoma.